Rheumatology Archives - Page 4 of 5

Cost effectiveness of adalimumab for the treatment of ankylosing spondylitis in the United Kingdom

Authors: M F Botteman, J W Hay, M P Luo, A S Curry, R L Wong, B A van Hout Published: Rheumatology (Oxford), 2010 View publication Objective This study evaluated the cost...

Fingolimod reduces direct medical costs compared to natalizumab in patients with relapsing-remitting multiple sclerosis in The Netherlands

Authors: M Heisen, M J Treur, W S van der Hel, S T Frequin, M T Groot, B G Verheggen Published: Journal of Medical Economics, 2012 View publication Objectives To assess the...

Eliciting health state utilities for Dupuytren’s contracture using a discrete choice experiment

Authors: N Y Gu, M F Botteman, R A Gerber, X Ji, R Postema, Y Wan, G Sianos, I Anthony, J C Cappelleri, P Szczypa, B van Hout Published: Acta Orthopaedica, 2013...

Modelling the cost-effectiveness of combination therapy for early, rapidly progressing rheumatoid arthritis by simulating the reversible and irreversible effects of the disease

Authors: S Stephens, M F Botteman, M A Cifaldi, B A van Hout Published: BMJ Open, 2015 View publication Objective To estimate the cost-effectiveness of adalimumab plus methotrexate (MTX) versus MTX monotherapy...

Burden of dose escalation with tumour necrosis factor inhibitors in rheumatoid arthritis: a systematic review of frequency and costs

Authors: R J Moots, R Mays, J Stephens, M Tarallo Published: Clinical and Experimental Rheumatology, 2015 View publication Objective Optimising therapy to minimise disease activity is the goal for treating rheumatoid arthritis...

Cost effectiveness of surgical versus non-surgical treatment of adults with displaced fractures of the proximal humerus: economic evaluation alongside the PROFHER trial

Authors: B Corbacho, D Duarte, A Keding, H Handoll, L H Chuang, D Torgerson, S Brealey, L Jefferson, C Hewitt, A Rangan Published: The Bone & Joint Journal, 2016 View publication Aim...

Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: a Cost-Effectiveness Analysis.

Authors: F Pierotti, I Palla, M Treur, L Pippo, G Turchetti Published: PLoS One, 2015 View publication Objective The purpose of this analysis is to evaluate the cost-effectiveness of belimumab, a new...

Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus

Authors: C Eckmann, D Nathwani, W Lawson, S Corman, C Solem, J Stephens, C Macahilig, J Li, C Charbonneau, N Baillon-Plot, S Haider Published: Clinical Microbiology and Infection, 2015 View publication Abstract...

Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections

Authors: M Dryden, M Baguneid, C Eckmann, S Corman, J Stephens, C Solem, J Li, C Charbonneau, N Baillon-Plot, S Haider Published: Clinical Microbiology and Infection, 2015 View publication Abstract Diabetes mellitus...

News